Vaccination 2021

On May 12 of this year, at the facilities of the Latin American Institute of Biotechnology, MECHNIKOV was carried out the annual influenza immunization program with the Flu-M vaccine manufactured by the same Institute. Free vaccination was available to both Institute employees and their families. The objective of immunization against influenza is to provide protection

The World Health Organization (WHO) has confirmed compliance with international quality standards for the Inactivated Split Influenza Vaccine produced by the Saint Petersburg’s Scientific Research Institute of Vaccine and Serum (SPbSRIVS), which is the parent company of the Latin-American Institute of Biotechnology MECHNIKOV in Nicaragua and supplies the bulk product of the vaccine for formulation,

The Mechnikov Institute, SA. In October 2020 has obtained the Sanitary Registration Certificate for the vaccine in the Republic of El Salvador. The Sanitary Registry granted by the National Directorate of Medicines of El Salvador is valid for 5 years. Registration obtained in El Salvador will allow the country to have an affordable quality vaccine

According to the regulatory norms of any country it is necessary to register the product before its commercialization and distribution. The main objective of this is to allow the regulatory agency to ensure and guarantee the supervision, surveillance and quality control of the product. Instituto Latinoamericano de Biotecnología MECHNIKOV with a mission to bring high-quality

Today, December 28 of the current year, the Instituto de Latinoamérica de Biotecnología MECHNIKOV S.A. made a contribution to the Ministry of Health of the Republic of Nicaragua (MINSA) with 20 thousand doses of the fractionated inactivated influenza vaccine. The delivery to the Health Ministry of Nicaragua made by the MECHNIKOV Institute is also a

Round Table

In the framework of the Conference organized by the Ministry of Industry and Trade of the Russian Federation together with the State Institute of Medicines and Good Practices, the General Manager of the InstituteMECHNIKOV Stanislav Uiba made a presentation on the Institute’s experience during the GMP Certification and Registration process by the Centro para el

On June 25, at the age of 67, pased away Dr. Rafael Pérez Cristiá, Director of the Center for the State Control of Medicines, Equipment and Medical Devices (CECMED), Doctor of Medical Sciences, Head of the Academy of Sciences of Cuba. The collaborators of the MECHNIKOV Institute mourn their irreparable loss and wish to extend

The Russian offer may be the best option for Latin America in the face of the coronavirus. The country has an advanced biotechnology industry and successful international experience. In this context, the Instituto de Latinoamérica de Biotecnología Mechnikov [ILBM], a vaccine plant installed in Nicaragua with Russian technology, is an exemplary case. Its the general

Vaccination 2020

The Latin American Institute of Biotechnology MECHNIKOV, on May 4 of this year, carried out a vaccination program against influenza for its collaborators and their families with the same vaccine manufactured by the Institute. Preventive vaccination against Flu allows minimizing the risks of co-infection both in medical personnel and in risk groups, which coincide with

Vaccination day in Nicaragua

Latin American Institute of Biotechnology MECHNIKOV delivered 600,000 doses of the influenza vaccine to the Nicaraguan Ministry of Health for the vaccination session.The MECHNIKOV Institute guarantees the delivery of vaccines in thermal boxes with cold accumulators to guarantee the quality of the product in the temperature range required for its transportation from our plant to

Russia collaborated in the delivery of 8,000 doses of Interferon Alpha 2B – a drug planned to be used against the Coronavirus – to Nicaragua, the St. Petersburg Institute for Scientific Research on Vaccines and Serums told TASS on Friday. Interferon Alpha 2B was delivered to Nicaragua from Cuba with logistical coordination from the Latin

The executive president of the Nicaraguan Institute of Social Security (INSS), Roberto López, reported this Thursday that Interferon Alpha 2B, a Cuban drug that is used within the spectrum of drugs to treat patients infected by coronavirus, could begin to be produced in Nicaragua . López, made a tour of the Mechnikov vaccine plant (Managua)